Fiduciary Trust Co Cuts Position in Morgan Stanley (NYSE:MS)

Fiduciary Trust Co lowered its stake in shares of Morgan Stanley (NYSE:MS - Free Report) by 2.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 366,242 shares of the financial services provider's stock after selling 8,116 shares during the period. Fiduciary Trust Co's holdings in Morgan Stanley were worth $38,177,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MS. Healthcare of Ontario Pension Plan Trust Fund raised its stake in shares of Morgan Stanley by 382.4% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,597,800 shares of the financial services provider's stock worth $166,555,000 after buying an additional 1,266,600 shares during the last quarter. Swedbank AB purchased a new position in Morgan Stanley during the 1st quarter valued at about $87,558,000. Fisher Asset Management LLC raised its position in Morgan Stanley by 2.7% during the third quarter. Fisher Asset Management LLC now owns 22,404,981 shares of the financial services provider's stock worth $2,335,495,000 after acquiring an additional 590,872 shares during the last quarter. Zurich Insurance Group Ltd FI purchased a new stake in shares of Morgan Stanley in the second quarter valued at about $43,850,000. Finally, Raymond James & Associates grew its position in shares of Morgan Stanley by 19.8% in the third quarter. Raymond James & Associates now owns 2,077,282 shares of the financial services provider's stock valued at $216,536,000 after purchasing an additional 343,234 shares during the last quarter. 84.19% of the stock is currently owned by institutional investors and hedge funds.

Morgan Stanley Stock Performance

NYSE:MS opened at $131.20 on Thursday. The company has a market cap of $211.37 billion, a P/E ratio of 19.97, a P/E/G ratio of 1.24 and a beta of 1.34. The firm's 50 day moving average is $118.10 and its two-hundred day moving average is $105.96. Morgan Stanley has a fifty-two week low of $76.33 and a fifty-two week high of $136.24. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 3.14.

Morgan Stanley (NYSE:MS - Get Free Report) last issued its earnings results on Wednesday, October 16th. The financial services provider reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.31. Morgan Stanley had a return on equity of 12.58% and a net margin of 10.64%. The business had revenue of $15.38 billion for the quarter, compared to analyst estimates of $14.27 billion. Analysts expect that Morgan Stanley will post 7.32 EPS for the current year.

Morgan Stanley Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were issued a $0.925 dividend. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $3.70 annualized dividend and a yield of 2.82%. Morgan Stanley's payout ratio is 56.32%.

Insider Buying and Selling at Morgan Stanley

In other Morgan Stanley news, Director Stephen J. Luczo sold 60,000 shares of the firm's stock in a transaction dated Thursday, October 17th. The stock was sold at an average price of $119.17, for a total value of $7,150,200.00. Following the transaction, the director now directly owns 138,363 shares of the company's stock, valued at $16,488,718.71. This trade represents a 30.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.24% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Jefferies Financial Group lifted their price objective on Morgan Stanley from $120.00 to $135.00 and gave the stock a "buy" rating in a research report on Thursday, October 17th. Citigroup boosted their price target on Morgan Stanley from $105.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday. Hsbc Global Res lowered Morgan Stanley from a "strong-buy" rating to a "hold" rating in a research note on Tuesday. The Goldman Sachs Group lifted their price objective on Morgan Stanley from $106.00 to $121.00 and gave the stock a "neutral" rating in a research report on Thursday, October 17th. Finally, UBS Group upped their target price on shares of Morgan Stanley from $102.00 to $112.00 and gave the company a "neutral" rating in a report on Tuesday, October 8th. Twelve investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Morgan Stanley has a consensus rating of "Hold" and an average target price of $115.63.

Morgan Stanley Profile

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.